Pluri Inc. (TLV:PLUR)
1,033.00
-10.00 (-0.96%)
At close: Jan 30, 2026
Pluri Revenue
Pluri had revenue of $316.00K USD in the quarter ending September 30, 2025, a decrease of -3.07%. This brings the company's revenue in the last twelve months to $1.33M, up 121.74% year-over-year. In the fiscal year ending June 30, 2025, Pluri had annual revenue of $1.34M with 309.82% growth.
Revenue (ttm)
$1.33M
Revenue Growth
+121.74%
P/S Ratio
24.50
Revenue / Employee
$9.34K
Employees
142
Market Cap
107.56M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.34M | 1.01M | 309.82% |
| Jun 30, 2024 | 326.00K | 39.00K | 13.59% |
| Jun 30, 2023 | 287.00K | 53.00K | 22.65% |
| Jun 30, 2022 | 234.00K | - | - |
| Jun 30, 2021 | - | - | - |
| Jun 30, 2020 | 23.00K | -31.00K | -57.41% |
| Jun 30, 2019 | 54.00K | 4.00K | 8.00% |
| Jun 30, 2018 | 50.00K | - | - |
| Jun 30, 2017 | - | - | - |
| Jun 30, 2016 | 2.85M | 2.47M | 651.19% |
| Jun 30, 2015 | 379.00K | - | - |
| Jun 30, 2014 | 379.00K | -300.00K | -44.18% |
| Jun 30, 2013 | 679.00K | -37.00K | -5.17% |
| Jun 30, 2012 | 716.00K | - | - |
| Jun 30, 2011 | - | - | - |
| Jun 30, 2010 | - | - | - |
| Jun 30, 2009 | - | - | - |
| Jun 30, 2008 | - | - | - |
| Jun 30, 2007 | - | - | - |
| Jun 30, 2006 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BioLineRx | 42.17M |
| Evogene | 26.54M |
| XTL Biopharmaceuticals | 3.26M |
| Can-Fite BioPharma | 1.89M |
| Clal Biotechnology Industries | 91.00K |
| Geffen Residence & Renewal | 84.00K |
| BioLight Life Sciences | 21.00K |